Shaloo Gupta1, Amir Goren2, Peng Dong3, Dongdong Liu3. 1. a Health Outcomes Practice , Kantar Health , Princeton , NJ , USA. 2. b Health Outcomes Practice, Kantar Health , New York , NY , USA. 3. c Health Economics & Outcomes Research , Pfizer Investment Co., Ltd , Beijing , China.
Abstract
OBJECTIVES: This cross-sectional study examined the prevalence and burden of major depressive disorder (MDD) among adults in urban China. METHODS: Data were included from the 2012 China National Health and Wellness Survey. Respondents self-reporting physician diagnosis of depression and screening positive for MDD (Patient Health Questionnaire-9), plus those screening positive for MDD, but undiagnosed and not experiencing depression, were compared with non-depressed controls. Outcomes included health-related quality of life (HRQoL), productivity loss, and resource utilization. Multivariable models assessed outcomes as a function of MDD, controlling for covariates. RESULTS: MDD prevalence was 6.0%; only 8.3% of these respondents were diagnosed, among whom 51.5% currently used prescription medication for depression. Adults with MDD (diagnosed or undiagnosed) reported significantly poorer HRQoL and greater productivity loss and resource utilization than controls. CONCLUSIONS: MDD in urban China may be under-diagnosed and undertreated. Awareness and better access to treatments may help alleviate the burden of MDD.
OBJECTIVES: This cross-sectional study examined the prevalence and burden of major depressive disorder (MDD) among adults in urban China. METHODS: Data were included from the 2012 China National Health and Wellness Survey. Respondents self-reporting physician diagnosis of depression and screening positive for MDD (Patient Health Questionnaire-9), plus those screening positive for MDD, but undiagnosed and not experiencing depression, were compared with non-depressed controls. Outcomes included health-related quality of life (HRQoL), productivity loss, and resource utilization. Multivariable models assessed outcomes as a function of MDD, controlling for covariates. RESULTS:MDD prevalence was 6.0%; only 8.3% of these respondents were diagnosed, among whom 51.5% currently used prescription medication for depression. Adults with MDD (diagnosed or undiagnosed) reported significantly poorer HRQoL and greater productivity loss and resource utilization than controls. CONCLUSIONS:MDD in urban China may be under-diagnosed and undertreated. Awareness and better access to treatments may help alleviate the burden of MDD.
Entities:
Keywords:
health-related quality of life; major depressive disorder; prevalence; productivity loss; resource utilization; urban China
Authors: Shasha Yu; Hongmei Yang; Xiaofan Guo; Liqiang Zheng; Yingxian Sun Journal: Int J Environ Res Public Health Date: 2016-05-28 Impact factor: 3.390
Authors: Manish K Jha; Raymond B Teer; Abu Minhajuddin; Tracy L Greer; A John Rush; Madhukar H Trivedi Journal: Neuropsychiatr Dis Treat Date: 2017-03-15 Impact factor: 2.570
Authors: Le Shi; Zheng-An Lu; Jian-Yu Que; Xiao-Lin Huang; Lin Liu; Mao-Sheng Ran; Yi-Miao Gong; Kai Yuan; Wei Yan; Yan-Kun Sun; Jie Shi; Yan-Ping Bao; Lin Lu Journal: JAMA Netw Open Date: 2020-07-01